Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Svrcek

Showing results (251-260 of 299) with videos related to

Pageof 30
Sort By:
Cancers|November 23, 2019
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 StatusJerome Raffenne, Remy Nicolle, Francesco Puleo, et al.
Nature Communications|November 6, 2023
Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slidesCharlie Saillard, Rémy Dubois, Oussama Tchita, et al.
Gastroenterology|August 31, 2018
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment FeaturesFrancesco Puleo, Rémy Nicolle, Yuna Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instabilityMagali Svrcek, Jamila El-Bchiri, Alexandra Chalastanis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort studyF Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2012
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinomaJ B Bachet, R Maréchal, P Demetter, et al.
Ebiomedicine|May 17, 2025
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastasesJulien Viot, Romain Loyon, Nawfel Adib, et al.
International Journal of Cancer|November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohortThomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2022
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II StudyThierry André, David Tougeron, Guillaume Piessen, et al.
Bulletin Du Cancer|February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Pageof 30

Showing results (251-260 of 299) with videos related to

Sort By:
Pageof 30
Cancers|November 23, 2019
hENT1 Testing in Pancreatic Ductal Adenocarcinoma: Are We Ready? A Multimodal Evaluation of hENT1 StatusJerome Raffenne, Remy Nicolle, Francesco Puleo, et al.
Nature Communications|November 6, 2023
Validation of MSIntuit as an AI-based pre-screening tool for MSI detection from colorectal cancer histology slidesCharlie Saillard, Rémy Dubois, Oussama Tchita, et al.
Gastroenterology|August 31, 2018
Stratification of Pancreatic Ductal Adenocarcinomas Based on Tumor and Microenvironment FeaturesFrancesco Puleo, Rémy Nicolle, Yuna Blum, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Specific clinical and biological features characterize inflammatory bowel disease associated colorectal cancers showing microsatellite instabilityMagali Svrcek, Jamila El-Bchiri, Alexandra Chalastanis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 16, 2020
Prognostic and predictive value of the Immunoscore in stage III colon cancer patients treated with oxaliplatin in the prospective IDEA France PRODIGE-GERCOR cohort studyF Pagès, T André, J Taieb, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 2, 2012
Contribution of CXCR4 and SMAD4 in predicting disease progression pattern and benefit from adjuvant chemotherapy in resected pancreatic adenocarcinomaJ B Bachet, R Maréchal, P Demetter, et al.
Ebiomedicine|May 17, 2025
Deciphering human endogenous retrovirus expression in colorectal cancers: exploratory analysis regarding prognostic value in liver metastasesJulien Viot, Romain Loyon, Nawfel Adib, et al.
International Journal of Cancer|November 13, 2020
Panel gene profiling of small bowel adenocarcinoma: Results from the NADEGE prospective cohortThomas Aparicio, Magali Svrcek, Julie Henriques, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2022
Neoadjuvant Nivolumab Plus Ipilimumab and Adjuvant Nivolumab in Localized Deficient Mismatch Repair/Microsatellite Instability-High Gastric or Esophagogastric Junction Adenocarcinoma: The GERCOR NEONIPIGA Phase II StudyThierry André, David Tougeron, Guillaume Piessen, et al.
Bulletin Du Cancer|February 15, 2020
[Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]Romain Cohen, Thomas Pudlarz, Marie-Line Garcia-Larnicol, et al.
Pageof 30